Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

TOMI Environmental Solutions Issues Blog Post Highlighting "The Need For Infection Prevention To Combat Mpox"

Author: Benzinga Newsdesk | August 15, 2024 10:13am

https://www.steramist.com/our-company/blogs-insights/mpox-global-emergency/

The Need for Infection Prevention to Combat Mpox

The latest virus outbreak, mpox, formerly known as monkeypox, has prompted the World Health Organization (WHO) to call for an emergency meeting. This urgent response follows a surge of mpox cases in the Democratic Republic of Congo and surrounding African countries.

Understanding Mpox

Mpox is a viral disease belonging to the same family as the smallpox virus. It is classified as a zoonosis, meaning it is transmitted from animals to humans. Mpox cases are frequently found near tropical rainforests, where animals known to carry the virus, such as squirrels, Gambian poached rats, dormice, and various monkey species, reside.

Symptoms and Spread of MPXV

The most prominent symptom of mpox or MPXV is the development of lesions or rashes, typically appearing around the face and mouth but potentially spreading to other body areas. Additional symptoms may include fever, swollen lymph nodes, headaches, chills, exhaustion, and muscle aches.

Global travel raises concerns about the spread of the mpox virus (MPXV) due to its rapid transmission. The most effective way to curb the spread of mpox is through prevention. Early detection and rapid disinfection of affected areas are crucial.

Preventing Mpox with EPA Registered Disinfection

In the face of rare or novel viruses like mpox (MPXV), finding suitable disinfectants can be challenging. However, SteraMist has been included on the Environmental Protection Agency (EPA) list of "Disinfectants for Emerging Viral Pathogens (EVPs): List Q" for its BIT solution. This recognition highlights the effectiveness of SteraMist products in combating the spread of emerging viruses like Mpox.  

SteraMist's long-standing customer base, including laboratories utilizing SteraMist disinfection to control the mpox virus, further attests to its efficacy.

Call to Action

Given the current mpox outbreak, it is crucial to prioritize infection prevention measures. SteraMist offers EPA-registered disinfection solutions that can help combat the spread of this emerging viral threat. By taking proactive steps and utilizing effective disinfection solutions like SteraMist, we can work together to mitigate the impact of the mpox outbreak and protect public health. For more information on SteraMist disinfection products and how they can protect against mpox, click here.

Posted In: TOMZ

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist